This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Oct. 12, 2011

Home   Membership   FAQ's   Bylaws    Mission Statement    Jobs   History   Contact Us


SGI Call for Abstracts deadline: Friday, Oct. 14, 2011

SGI Online Abstract Submission Program for 2012

SGI Preliminary Program Meeting at a Glance

SGI Annual Scientific Meeting — March 21-24, 2012

Provisional Program Details

2012 SGI Meeting Registration Form

Provisional Highlights

SGI Satellites

Fetal Physiology, Myometrium, Preterm Birth, Placenta, Endometrium

SGI Plenary Lectures

Dr. Leroy Hood (Seattle) "Individualized Medicine" Dr. Janet Rossant (Toronto) "Stem Cells and Individualized Medicine" Dr. David Relman (Stanford) "Microbiome and Individualized Medicine"

SGI Mini-symposia

New Frontiers in Placental Biology

The Art and Science of Embryo Selection

Obesity: Impact on Reproduction and Development:

Reproductive Epigenomic Health

Stem Cells and Reproductive Health

Women and Children’s Health: A Global Perspective

Maternal Health Following Complicated Pregnancies

Aging and Reproductive Function

Personalized Medicine in Reproductive Health

Corticotropin Releasing Factor (CRF) and Reproduction: A 30-Year Journey

Early Programming of Lifelong Health: A Focus on Mechanism

The Microbiome in Pregnancy and its Relationship to Health and Disease

Is it a bad idea to run a marathon while pregnant?
Time Magazine    Share    Share on
FacebookTwitterShare on LinkedinE-mail article
Few moms would deny that pregnancy, with its 40 long weeks of growing a baby, feels like a marathon. But Amber Miller of Westchester, Ill., gave that simile a literal twist: on Oct. 9, with a little more than a week to go before her due date, she ran — and walked — the Chicago Marathon, beating her husband's time and welcoming her new daughter seven hours after crossing the finish line. More

Doctors emphasize science as politics impedes HPV vaccine use
Chicago Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Public health officials in the Chicago area have been well aware that passionate debates about the HPV vaccine were raging long before the recent dust-up between U.S. Rep. Michele Bachmann and fellow GOP presidential candidate Rick Perry over Perry's attempt as Texas governor to mandate the vaccine for girls. But since the issue arose in the GOP debate in September, many physicians have been spending more time reassuring parents about the vaccine's safety and efficacy. More

Chemical makers say BPA no longer used in bottles
USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Makers of the controversial chemical bisphenol-A have asked federal regulators to phase out rules that allow its use in baby bottles and sippy cups, saying those products haven't contained the plastic-hardening ingredient for two years. The unusual request from the American Chemistry Council may help quash years of negative publicity from consumer groups and head off tougher laws that would ban the chemical from other types of packaging because of health worries. For now, the industry says concerns over bottles and spill-proof cups are unnecessary. More

Economy affects physician career choices
The Memphis Daily News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The prolonged recession has impacted the career choices of physicians graduating from the University of Tennessee Health Science Center College of Medicine, with graduates choosing to enter higher-paying specialties and sub-specialties over primary care when the economic outlook was at its worst. "We have actually trended our students’ career choices over the past four or five years and things have changed," said Dr. Owen Phillips, associate dean of Student Affairs at the UTHSC College of Medicine and a professor in the Department of Obstetrics and Gynecology. More

FDA: Cancer drug Avastin may cause ovarian failure in women
International Business Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Treatment with the cancer drug Avastin might affect fertility in some women, the U.S. Food and Drug Administration said, the latest side effect that has been reported in connection with the medication. Avastin may increase the risk of "ovarian failure" by causing ovaries to stop releasing eggs regularly, according to the FDA. The agency said the drug's warning label will now recommend that doctors tell women of child-bearing age about the risk before they begin treatment. More

Massachusetts doctor 'optimistic' about cancer treatment
The Taunton Daily Gazette    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Dr. Arlan Fuller, the clinical vice president for the integration of oncology services and academic affiliations at Winchester Hospital in Winchester, Mass., says he is optimistic about the recent advancements that have been made toward understanding cancer. Fuller said the understanding of cancer cells has changed greatly since scientists released an initial draft of the findings of the Human Genome Project in 2001. The Human Genome Project, begun in 1990 by the U.S. Department of Energy and the National Institutes of Health, was essentially an effort to identify and gather information on the more than 20,000 genes in human DNA. More

New Richmond Heights practice offers holistic gynecology
Clayton-Richmond Heights Patch    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Dr. Poppy Daniels wants her new Richmond Heights practice near St. Louis to facilitate cooperation between doctors and midwives to provide women with the best possible health care. The Poplar Bluff, Mo., resident watched those two groups of people work together during her obstetrics and gynecology residency program at Drexel University in Philadelphia. But upon returning home, she was surprised to learn that Missouri's support of midwifery was "far behind" that of other states. More

Physician says review needed on decision to not fund IVF
The Toronto Star    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A Canadian physician says infertility poses a challenge for everyone. While most medical initiatives seek to save or extend life, fertility treatments help to create new life. In these challenging economic times, as we scrutinize all health expenses, it’s worthwhile to revisit the human, moral and economic costs and consequences of not funding in vitro fertilization (IVF). More

Popular Florida TV journalist credits acupuncture for pregnancy
Medill Reports - Chicago    Share    Share on FacebookTwitterShare on LinkedinE-mail article
After suffering through the pain and sadness of three miscarriages and spending around $20,000 on fertility treatments, popular Florida news anchor Stacey Adams, 40, felt she had run out of options for ever having a child. Then Adams turned to acupuncture. The research is mixed on whether and how acupuncture can improve fertility, but Adams said she saw results almost immediately after nearly giving up hope. More

Premature births: Does traffic pollution play a role?
The Huffington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
New research suggests traffic-related air pollution might play a role, significantly increasing the risk of giving birth before 37 weeks. Researchers with the University of California analyzed the birth certificates of children born to Los Angeles women living near several air quality monitoring stations. They found that exposure to traffic-related pollutants was associated with a 30 percent increased risk of preterm birth. The new study highlighted polycyclic aromatic hydrocarbons (PAHs) as a pollutant of particular concern. More

Study: Pregnancy drug raised daughters' cancer odds
The Associated Press via The Salt Lake Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems that are showing up now, a new federal study finds. Many of these daughters, now over 40, may not even know of their risk if their mothers never realized or told them they had used the drug, a synthetic estrogen called DES. The new study suggests that infertility is twice as common and that breast cancer risk is nearly doubled in these daughters. More

The new front in breast cancer: After treatment ends
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The mastectomy, chemotherapy, radiation and hormone treatments are behind them. Now, the growing ranks of breast cancer survivors face long-term issues that are often overlooked. "The second-hardest phase — after the initial diagnosis — is the minute your treatment ends," says Carie Capossela, 43 years old, who marked 10 years as a breast-cancer survivor in June. Despite all the pink ribbons and billions spent on breast-cancer research, there is surprisingly little data on issues that linger or emerge for the 10, 15 or more years after treatment ends. Although the odds of relapse fall with time, they never completely disappear. More

Eye on SGI
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Keila Mack, Content Editor, 469.420.2637   
Contribute news

This edition of Eye on SGI was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Oct. 5, 2011
Sept. 28, 2011
Sept. 21, 2011
Sept. 14, 2011

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063